Alzheimer's Drug Development Pipeline Shows Impressive Growth and Diversity of Therapies
Kirk Kerkorian School of Medicine at UNLV
Aannual report on the global effort to find a cure for Alzheimer's shows a 35% increase in the number of clinical trials and a 40% increase in therapies being tested since 2016. Significantly, 59 new trials entered the pipeline during the past year signaling an increased confidence in the ability to develop drugs to slow the loss of memory.